lysergic acid diethylamide has been researched along with Refractory Depression in 2 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tullis, P | 1 |
| Rucker, JJ | 1 |
| Jelen, LA | 1 |
| Flynn, S | 1 |
| Frowde, KD | 1 |
| Young, AH | 1 |
1 review available for lysergic acid diethylamide and Refractory Depression
| Article | Year |
|---|---|
Psychedelics in the treatment of unipolar mood disorders: a systematic review.
Topics: Depressive Disorder, Treatment-Resistant; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Di | 2016 |
1 other study available for lysergic acid diethylamide and Refractory Depression
| Article | Year |
|---|---|
How ecstasy and psilocybin are shaking up psychiatry.
Topics: Animals; Certification; Clinical Trials as Topic; Depression; Depressive Disorder, Treatment-Resista | 2021 |